CuraScientific Corp

CSTFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$377345

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume16K

Open$0.00

Beta-3.96

Free Cash Flow Financials Revenue

CuraScientific Corp (CSTF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CSTF · free cash flow · updated Jun 9, 2026

Core FCF metrics

CSTF · FCF · TTM · margin & CAGR

Free cash flow was −$268,624 for FY2022 (fiscal year ending 2022-12-31), up 52.0% year-over-year The FCF margin was -780.1%.

FY2022 Free Cash Flow−$268,624▲ +52.0% YoY

Trailing 12M (TTM)−$401,988trailing 4 quarters sum

FCF Margin-780.1%−$268,624 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CSTF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$253,710(0M)−$268,624▲ +52.0%-780.1%

FY2021−$553,772(0M)−$559,386▼ 29.1%-648.5%

FY2020−$433,389(0M)−$433,389▼ 33489.0%-720.4%

FY2019$1,298(0M)$1,298▼ 88.9%1.6%

FY2018$11,704(0M)$11,704▲ +148.0%13.7%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CSTF · P/FCF · FCF yield · FCF per share

CuraScientific Corp (CSTF) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

CSTF · cash flow statement · operating / investing / financing

For FY2022, CuraScientific Corp generated −$0.3M in operating cash flow and spent 0M in capital expenditures, yielding −$0.3M in free cash flow.

Operating Activities

−$0.3M

Cash from core business operations

2022-12-31

Investing Activities

−$0.0M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

+$0.2M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$0.3M) − |CapEx| (0M) = FCF (−$0.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CSTF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CuraScientific CorpYOU

CSTF

−$268,624+52.0%-780.1%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CuraScientific Corp (CSTF) reported free cash flow of −$268,624 for FY2022 (fiscal year ending 2022-12-31), up 52.0% year-over-year. The FCF margin was -780.1%.

Based on available data, CuraScientific Corp has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $11,704 in FY2018.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CSTF free cash flow · 8 questions

CuraScientific Corp free cash flow was −$268,624 for FY2022, up 52.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$401,988.

CSTF free cash flowCSTF FCFCSTF FCF 2022CSTF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CuraScientific Corp · CuraScientific Corp SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026